Literature DB >> 8494385

In vitro antimicrobial susceptibilities of Nocardia species.

N Khardori1, R Shawar, R Gupta, B Rosenbaum, K Rolston.   

Abstract

The in vitro activities of various quinolones, two new aminoglycosides, a new cephamycin analog (cefmetazole) and a new spectinomycin analog (trospectomycin), imipenem, and trimethoprim-sulfamethoxazole against 26 isolates of Nocardia asteroides, 7 isolates of N. brasiliensis, and 6 isolates of N. caviae were determined by a broth microdilution method. The three new quinolones, PD 117558, PD 117596 and PD 112739, inhibited 90% of N. asteroides at 1 to 2 micrograms/ml, and two new aminoglycosides, SCH 21420 and SCH 22591, inhibited 90% of N. asteroides at 2 to 4 micrograms/ml. Among the beta-lactams, cefmetazole was more active than imipenem. N. brasiliensis and N. caviae isolates were also very susceptible to the three quinolones (MICs for 50% of the isolates, 0.25 to 1 microgram/ml) and the two aminoglycosides (MICs for 50% of the isolates, 1 to 2 micrograms/ml). Cefmetazole was moderately active against N. brasiliensis, whereas imipenem showed poor activity against both of these species.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8494385      PMCID: PMC187795          DOI: 10.1128/AAC.37.4.882

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  20 in total

1.  Activity of new quinolones against ciprofloxacin-resistant staphylococci.

Authors:  G J Forstall; C C Knapp; J A Washington
Journal:  Antimicrob Agents Chemother       Date:  1991-08       Impact factor: 5.191

Review 2.  Synergy and antagonism of combinations with quinolones.

Authors:  H C Neu
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-04       Impact factor: 3.267

3.  In vitro activities of 4-quinolones against the fish pathogen Aeromonas salmonicida.

Authors:  A C Barnes; C S Lewin; T S Hastings; S G Amyes
Journal:  Antimicrob Agents Chemother       Date:  1990-09       Impact factor: 5.191

4.  Antimicrobial susceptibility patterns of Nocardia asteroides.

Authors:  R J Wallace; L C Steele; G Sumter; J M Smith
Journal:  Antimicrob Agents Chemother       Date:  1988-12       Impact factor: 5.191

5.  Susceptibility testing of Nocardia species for the clinical laboratory.

Authors:  R J Wallace; L C Steele
Journal:  Diagn Microbiol Infect Dis       Date:  1988-03       Impact factor: 2.803

6.  In vitro susceptibilities of Nocardia species to newer antimicrobial agents.

Authors:  P Berkey; D Moore; K Rolston
Journal:  Antimicrob Agents Chemother       Date:  1988-07       Impact factor: 5.191

Review 7.  The clinical spectrum of Nocardia brasiliensis infection in the United States.

Authors:  R A Smego; H A Gallis
Journal:  Rev Infect Dis       Date:  1984 Mar-Apr

8.  Comparative in vitro activities of newer quinolones against Pseudomonas species and Xanthomonas maltophilia isolated from patients with cancer.

Authors:  K V Rolston; M Messer; D H Ho
Journal:  Antimicrob Agents Chemother       Date:  1990-09       Impact factor: 5.191

Review 9.  Newly documented antimicrobial activity of quinolones.

Authors:  Y X Furet; J C Pechère
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-04       Impact factor: 3.267

10.  Beta-lactam resistance in Nocardia brasiliensis is mediated by beta-lactamase and reversed in the presence of clavulanic acid.

Authors:  R J Wallace; D R Nash; W K Johnson; L C Steele; V A Steingrube
Journal:  J Infect Dis       Date:  1987-12       Impact factor: 5.226

View more
  6 in total

1.  Antimicrobial susceptibilities of Nocardia spp.

Authors:  C A Wood
Journal:  Antimicrob Agents Chemother       Date:  1993-11       Impact factor: 5.191

2.  Nocardia thyroiditis: unusual location of infection.

Authors:  C Carriere; H Marchandin; J M Andrieu; A Vandome; C Perez
Journal:  J Clin Microbiol       Date:  1999-07       Impact factor: 5.948

Review 3.  Imipenem/cilastatin: an update of its antibacterial activity, pharmacokinetics and therapeutic efficacy in the treatment of serious infections.

Authors:  J A Balfour; H M Bryson; R N Brogden
Journal:  Drugs       Date:  1996-01       Impact factor: 9.546

Review 4.  Clinical and laboratory features of the Nocardia spp. based on current molecular taxonomy.

Authors:  Barbara A Brown-Elliott; June M Brown; Patricia S Conville; Richard J Wallace
Journal:  Clin Microbiol Rev       Date:  2006-04       Impact factor: 26.132

5.  Antimicrobial susceptibilities of regional pathogenic strains of Nocardia isolated from mycetomas.

Authors:  E L Durán; A van Gelderen de Komaid
Journal:  Mycopathologia       Date:  1995-09       Impact factor: 2.574

6.  Nocardia veterana isolated from ascitic fluid of a patient with human immunodeficiency virus infection.

Authors:  Sylvain Godreuil; Marie-Noëlle Didelot; Colette Perez; Anne Leflèche; Patrick Boiron; Jacques Reynes; Frédéric Laurent; Hélène Jean-Pierre; Hélène Marchandin
Journal:  J Clin Microbiol       Date:  2003-06       Impact factor: 5.948

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.